This study aimed to investigate image quality for a comprehensive set of isotopes ( 18 F, 11 C, 89 Zr, 124 I, 68 Ga, and 90 Y) on 2 clinical scanners: a PET/CT scanner and a PET/MR scanner. Methods: Image quality and spatial resolution were tested according to NU 2-2007 of the National Electrical Manufacturers Association. An imagequality phantom was used to measure contrast recovery, residual bias in a cold area, and background variability. Reconstruction methods available on the 2 scanners were compared, including point-spreadfunction correction for both scanners and time of flight for the PET/ CT scanner. Spatial resolution was measured using point sources and filtered backprojection reconstruction. Results: With the exception of 90 Y, small differences were seen in the hot-sphere contrast recovery of the different isotopes. Cold-sphere contrast recovery was similar across isotopes for all reconstructions, with an improvement seen with time of flight on the PET/CT scanner. The lower-statistic 90 Y scans yielded substantially lower contrast recovery than the other isotopes. When isotopes were compared, there was no difference in measured spatial resolution except for PET/MR axial spatial resolution, which was significantly higher for 124 I and 68 Ga. Conclusion: Overall, both scanners produced good images with 18 F, 11 C, 89 Thefir st isotopes used in PET were those of elements common in the human body, such as 15 O, 13 N, and 11 C. They found applications in both research and clinical PET: 15 O measured brain blood flow (1); 13 N assessed myocardial perfusion (2); and 11 C was successful in several applications, such as brain tumor imaging (3), prostate cancer staging (4), and cardiology (5). The short half-lives of these isotopes require an on-site cyclotron, a limiting factor for their widespread use.PET grew rapidly from the late 1990s. Approval for reimbursement by the Centers for Medicare and Medicaid Services, the longer half-life of 18 F, and the simple uptake mechanism of 18 F-FDG were key factors for general use in oncology and other fields. More recently, 82 Rb found widespread applications in myocardial perfusion studies (6), and 68 Ga has been extensively used for somatostatin receptor imaging (7). Both are generator-produced and can therefore be used by PET centers without access to a cyclotron.The continuous evolution of PET is now bringing new applications for old positron-emitting isotopes. In oncology, molecular imaging is evolving from simply tracking the hypermetabolism of cancer cells into imaging target molecules specific to a unique mechanism, or monitoring and guiding medical therapy, as in immunotherapy and radioimmunotherapy (8,9). Monoclonal antibodies are growing dramatically as therapeutic target-specific agents (10); 124 I, 89 Zr, 86 Y, 76 Br, and 64 Cu have shown an excellent ability to label monoclonal antibodies, with half-lives matched to the rate of antibody accumulation in tumors or target organs. Another area of development is targeted radionuclide therapy-for example...